Alzheimer’s Drug Failure Gets a Second Life: Failed Simufilam Scaffold Reborn as PTP1B Inhibitor
Researchers redesigned 52 derivatives of the failed Alzheimer's drug simufilam to target PTP1B, a key enzyme in neuroinflammation, with lead ...
Researchers redesigned 52 derivatives of the failed Alzheimer's drug simufilam to target PTP1B, a key enzyme in neuroinflammation, with lead ...
Computational screening of four halogenated quinoline derivatives identifies QNL1 and QNL3 as promising oral drug candidates against tuberculosis, E. coli, ...
A systematic review of 252 studies published between 2024 and 2026 shows natural products dominating antimalarial discovery while warning that ...
Researchers combined mass spectrometry, machine learning and animal experiments to reveal how the traditional Chinese formula Bushen-Yizhi protects against Alzheimer's-like ...
Japanese researchers used an amino acid mapping descriptor derived from the natural antibiotic waldiomycin to screen nearly 12 million compounds ...
Researchers have isolated three phytochemicals from the roots of Hiptage madablota and used molecular docking to predict their interactions with ...
A new review maps how computational tools, from RNA folding algorithms to molecular dynamics simulations, are transforming the design of ...
A new framework called LLM-H2G fuses large language model semantics with hypergraph contrastive learning to predict herb–disease associations, outperforming existing ...
Researchers at the University of Qom have developed BT-Synergy, a hybrid BiLSTM-Transformer deep learning model that predicts synergistic cancer drug ...
The Nipah virus, one of the deadliest pathogens on the World Health Organization's priority list, has long haunted public health ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine